A clinical trial—a research study that screens and follows participants under a set protocol—qualifies you only if you meet that study's specific criteria. If accepted, you follow its visit schedule, while compensation amounts and payment dates vary by study. A promising listing is only a possible match, not an enrollment offer. Review the screening process, visit commitments, compensation, reimbursements, costs, and injury policy before consenting.
Official resources:
- Check eligibility on ClinicalTrials.gov’s official study page — Use this page to check the study’s participation requirements.
- View the official study record on ClinicalTrials.gov — Use this record to verify the study status and eligibility details.
Table of Contents
- Who qualifies for a clinical trial?
- What happens between applying and enrolling?
- How is the study scheduled?
- How does clinical trial payment work?
- What should you confirm before consenting?
Who qualifies for a clinical trial?
Eligibility depends on the question each study is designed to answer. Criteria may cover age, sex, medical condition, health history, previous treatment, or exposure history. These rules also help protect participants, according to ClinicalTrials.gov's study overview.
Meeting the most visible requirements does not guarantee acceptance. For example, someone may have the relevant condition and age but become ineligible because of previous treatment or another health-history requirement. Answer screening questions completely and accurately. Omitting information could prevent study staff from properly applying criteria intended to protect participants and produce useful results.
What happens between applying and enrolling?
prospective participants generally review study information and complete screening before enrollment. Screening may include questions, examinations, or tests that confirm whether the person meets every inclusion and exclusion rule, as described by the National Institute on Aging. You should also receive an informed-consent document.
NIH guidance says it should explain the study's purpose, expected duration, required procedures or tests, risks, possible benefits, and contact information. Consent is not a promise to remain until the end. Participation is voluntary, and you may leave at any time. Before signing, ask staff to explain any eligibility rule, procedure, risk, or payment term that is unclear.
How is the study scheduled?
After acceptance, participants typically schedule a baseline visit. This initial appointment begins the protocol-defined study activities and assessments. Follow-up visits occur according to the protocol.
Staff may perform assessments, collect research data, and monitor participant safety during these appointments. Before enrolling, compare the complete schedule with your actual availability. Ask the study contact for:.
- The number and timing of baseline and follow-up visits
- The tests, procedures, or assessments required at each stage
- Which activities trigger compensation
- The contact and process for scheduling questions
- What happens to accrued compensation if you withdraw
How does clinical trial payment work?
There is no standard clinical trial payment amount or schedule. The FDA's payment guidance says payment is generally acceptable but must be just and fair. An institutional review board, or IRB, reviews the amount, method, and timing for possible undue influence. Compensation and reimbursement are different. Compensation recognizes time, effort, and inconvenience.
Reimbursement covers out-of-pocket expenses such as travel and parking, so separate the two when evaluating what a study offers. FDA guidance recommends that payment credit accumulate as participants complete study activities rather than depend entirely on finishing the trial. A separate completion bonus may be permitted when it is reasonable and noncoercive. Consent materials should state the payment amount and schedule. NIH guidance also calls for the payment method and purpose, allowing candidates to connect each payment with the relevant activity or expense.
What should you confirm before consenting?
ClinicalTrials.gov records generally do not show participant payments or costs. Its patient questions page directs interested people to the listed study contact for details.
Ask for clear answers to these questions: For research involving more than minimal risk, the consent form must say whether compensation or medical treatment is available for a research-related injury. FDA guidance leaves the availability of that coverage to institutional policy, so read the provision rather than assuming coverage exists.
- What compensation is available for each completed activity?
- Is travel or parking reimbursement separate?
- How and when will each payment be issued?
- Is any payment reserved as a completion bonus?
- Are participants responsible for any study-related costs?
